教職

國防醫學院醫學系放射腫瘤學科臨床講師 2017年8月～迄今

經歷

三軍總醫院放射腫瘤部住院醫師 2017年8月～2020年7月
三軍總醫院放射腫瘤部總住院醫師 2020年8月～2021年7月
三軍總醫院放射腫瘤部資深住院醫師 2021年8月～2022年7月
三軍總醫院放射腫瘤部主治醫師 2022年8月～ ～迄今

專長學科

放射腫瘤學、輻射生物學、放射物理學
頭頸癌、肺癌、乳癌、消化道癌、泌尿道癌、骨腫瘤及軟組織肉瘤等腫瘤放射治療
影像導引放射治療
立體定位放射治療

論文發表

1: Tsao CC, Wu HH, Wang YF, Shen PC, Wu WT, Chen HY, Dai YH. Novel Inflammasome-
Based Risk Score for Predicting Survival and Efficacy to Immunotherapy in Early-
Stage Non-Small Cell Lung Cancer. Biomedicines. 2022 Jun 28;10(7):1539.
2: Shen PC, Wang YF, Chang HC, Huang WY, Lo CH, Su YF, Yang JF, Lin CS, Dai YH.
Developing a novel DNA methylation risk score for survival and identification of
prognostic gene mutations in endometrial cancer: a study based on TCGA data. Jpn
J Clin Oncol. 2022 May 9:hyac077.
3: Shen PC, Huang WY, Dai YH, Lo CH, Yang JF, Su YF, Wang YF, Lu CF, Lin CS.
Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in
Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body Radiotherapy.
Biomedicines. 2022 Mar 3;10(3):597.
4: Hsiang CW, Huang WY, Yang JF, Shen PC, Dai YH, Wang YF, Lin CS, Chang WC, Lo
CH. Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with
Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for
Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021 Oct 29;8:1299-1309. doi:
10.2147/JHC.S334933.
5: Dai YH, Wang YF, Shen PC, Lo CH, Yang JF, Lin CS, Chao HL, Huang WY. Gene-
associated methylation status of ST14 as a predictor of survival and hormone
receptor positivity in breast Cancer. BMC Cancer. 2021 Aug 21;21(1):945.
6: Dai YH, Wang YF, Shen PC, Lo CH, Yang JF, Lin CS, Chao HL, Huang WY.
Radiosensitivity index emerges as a potential biomarker for combined
radiotherapy and immunotherapy. NPJ Genom Med. 2021 Jun 2;6(1):40.

7: Wang YF, Dai YH, Lin CS, Chang HC, Shen PC, Yang JF, Hsiang CW, Lo CH, Huang
WY. Clinical outcome and pathologic correlation of stereotactic body radiation
therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a
case series. Radiat Oncol. 2021 Jan 14;16(1):15.
8: Lo CH, Lee HL, Hsiang CW, Chiou JF, Lee MS, Chen SW, Shen PC, Lin CS, Chang
WC, Yang JF, Dai YH, Chen CY, Chia-Hsien Cheng J, Huang WY. Pretreatment
Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients
With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation
Therapy. Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):474-484.
9: Huang WY, Tsai CL, Que JY, Lo CH, Lin YJ, Dai YH, Yang JF, Shen PC, Lee MH,
Cheng JC. Development and Validation of a Nomogram for Patients with
Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body
10: Chen SM, Lin KT, Dai YH, Chiang KT, Lee SY. Fighter Pilots With
Nasopharyngeal Carcinoma Successfully Returning to Flight After Radiotherapy: A
Case Series. Mil Med. 2020 Mar 2;185(3-4):e522-e525.
11: Tseng CC, Jia B, Barndt RB, Dai YH, Chen YH, Du PA, Wang JK, Tang HJ, Lin
CY, Johnson MD. The intracellular seven amino acid motif EEGEVFL is required for
matriptase vesicle sorting and translocation to the basolateral plasma membrane.
PLoS One. 2020 Feb 12;15(2):e0228874.
12: Yang JF, Lo CH, Lee MS, Lin CS, Dai YH, Shen PC, Chao HL, Huang WY.
Stereotactic ablative radiotherapy versus conventionally fractionated
radiotherapy in the treatment of hepatocellular carcinoma with portal vein
invasion: a retrospective analysis. Radiat Oncol. 2019 Oct 22;14(1):180.
13: Shen PC, Chang WC, Lo CH, Yang JF, Lee MS, Dai YH, Lin CS, Fan CY, Huang WY.
Comparison of Stereotactic Body Radiation Therapy and Transarterial
Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma. Int J
Radiat Oncol Biol Phys. 2019 Oct 1;105(2):307-318.
14: Chien FC, Dai YH, Kuo CW, Chen P. Flexible nanopillars to regulate cell
adhesion and movement. Nanotechnology. 2016 Nov 25;27(47):475101.
15: Chien FC, Lien CH, Dai YH. Dual-color dynamic tracking of GM-CSF
receptors/JAK2 kinases signaling activation using temporal focusing multiphoton
fluorescence excitation and astigmatic imaging. Opt Express. 2015 Nov
30;23(24):30943-55.
16: Dai YH, Yeo YH, Li YF, Hsieh CB, Shih YL. Hepatobiliary cystadenocarcinoma
without mesenchymal stroma in a female patient: a case report. BMC
Gastroenterol. 2014 Jun 16;14:109.
17: Dai YH, Ou KL, Chiang CM, Chu PW. An unusual cause of cerebellar and
oculomotor dysfunction by rapid infusion of meperidine. J Clin Anesth. 2014
Jun;26(4):331-2.
18: Li JT, Dai YH, Kuo SM. A massive retroperitoneal neuroblastoma with stenosis
of the inferior vena cava in a 5-month-old boy. BMJ Case Rep. 2014 Mar
26;2014:bcr2014203904.
19: Dai YH, Ou KL, Chu PW. Cerebellar and oculomotor dysfunction induced by
rapid infusion of pethidine. BMJ Case Rep. 2014 Mar 11;2014:bcr2014203868.
20: Ou KL, Dai YH, Wang HJ, Chen TM, Dai NT, Chang SC, Deng SC, Tzeng YS, Wang
CH, Chen SG. The lower trapezius musculocutaneous flap for head and neck
reconstruction: two decades of clinical experience. Ann Plast Surg. 2013 Dec;71
Suppl 1:S48-54.